In a tolerability study using high intravenous and oral doses of Mesna, single doses of 60 mg/kg body weight and above were associated with nausea-vomiting, diarrhoea, headache, joint pain, drop in blood pressure, tachycardia, skin reactions, exhaustion and weakness.
During treatment, the previously mentioned side-effects can not always be clearly differentiated from those caused by Oxazaphosphorines (Ifosfamide, Cyclophosphamide), or other concomitant medication.
View ADR Monitoring Form